#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	14424	16S	1529	1529	100.0	16S.l15.c17.ctg.1	2065	693.9	1	SNP	n	C1184T	0	.	.	1184	1184	C	1399	1399	C	876	C	810	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	14424	16S	1529	1529	100.0	16S.l15.c17.ctg.1	2065	693.9	0	HET	.	.	.	G1413GA	.	1413	1413	G	1628	1628	G	879	G,GA	673,173	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	14424	16S	1529	1529	100.0	16S.l15.c17.ctg.1	2065	693.9	0	HET	.	.	.	A37T	.	37	37	A	252	252	A	843	A,T	643,130	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	14424	16S	1529	1529	100.0	16S.l15.c17.ctg.1	2065	693.9	0	HET	.	.	.	C1525T	.	1525	1525	C	1740	1740	C	701	C,T	527,122	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25486	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3461	734.0	0	.	n	.	0	T695C	SNP	695	695	T	1008	1008	C	771	C	723	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25486	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3461	734.0	0	.	n	.	0	A1638G	SNP	1638	1638	A	1951	1951	G	874	G	811	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25486	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3461	734.0	0	.	n	.	0	T1971C	SNP	1971	1971	T	2284	2284	C	763	C,T	705,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25486	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3461	734.0	1	SNP	n	A2045G	0	.	.	2045	2045	A	2358	2358	A	740	A	685	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25486	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3461	734.0	1	SNP	n	C2597T	0	.	.	2597	2597	C	2910	2910	C	802	C	748	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25486	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3461	734.0	0	HET	.	.	.	A20C	.	20	20	A	333	333	A	507	A,C	171,311	.	.
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	528	16	blaTEM	861	432	99.54	blaTEM.l15.c30.ctg.1	432	1.9	0	.	p	.	0	M180T	NONSYN	538	540	ATG	183	185	ACG	2;2;2	A;C;G	2;2;2	.	Betalactam resistance
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	528	16	blaTEM	861	432	99.54	blaTEM.l15.c30.ctg.1	432	1.9	0	.	p	.	0	L247M	NONSYN	739	741	CTG	384	386	ATG	1;1;1	A,C;T;G	0,1;1;1	.	Betalactam resistance
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	1806	folP	855	855	100.0	folP.l6.c4.ctg.1	1501	119.5	1	SNP	p	R229S	1	.	.	685	687	AGC	956	958	AGC	173;171;172	A;G;C	164;162;161	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4818	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3259	147.2	1	SNP	p	S91F	1	.	.	271	273	TTC	519	521	TTC	165;167;164	T;T;C,A	151;153;148,1	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4818	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3259	147.2	1	SNP	p	G95N	0	.	.	283	285	GGC	531	533	GGC	170;174;171	G;G,T;C	155;157,1;157	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4818	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3259	147.2	1	SNP	p	D95G	1	.	.	283	285	GGC	531	533	GGC	170;174;171	G;G,T;C	155;157,1;157	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_F_01564	mtrR.WHO_F_01564	1	1	27	1564	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1277	121.9	1	SNP	p	G45D	0	.	.	133	135	GGC	473	475	GGC	195;197;198	G;G;C	178;177;183	mtrR.WHO_F_01564:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	746	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	783	93.9	0	.	n	.	0	.206T	INS	206	206	T	471	471	T	186	T	171	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4798	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2890	165.3	1	SNP	p	D86N	0	.	.	256	258	GAC	497	499	GAC	178;178;177	G;A;C	166;166;166	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4798	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2890	165.3	1	SNP	p	R87W	0	.	.	259	261	CGT	500	502	CGT	178;177;173	C;G;T	168;167;158	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4798	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2890	165.3	1	SNP	p	S87R	1	.	.	259	261	CGT	500	502	CGT	178;177;173	C;G;T	168;167;158	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4798	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2890	165.3	1	SNP	p	R87I	0	.	.	259	261	CGT	500	502	CGT	178;177;173	C;G;T	168;167;158	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4798	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2890	165.3	1	SNP	p	S88P	0	.	.	262	264	TCC	503	505	TCC	174;171;171	T;C;C	161;162;162	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3902	parE	1986	1986	100.0	parE.l6.c30.ctg.1	2742	141.9	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1588	1590	GGC	189;187;189	G;G;C	176;173;172	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	3728	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2301	161.2	1	SNP	p	A311V	0	.	.	931	933	GCA	1166	1168	GCA	213;211;209	G;C;A	190;192;189	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3728	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2301	161.2	1	SNP	p	I312M	0	.	.	934	936	ATC	1169	1171	ATC	209;212;216	A;T;C	190;189;196	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3728	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2301	161.2	1	SNP	p	V316T	0	.	.	946	948	GTG	1181	1183	GTG	209;208;207	G;T;G	188;183;185	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3728	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2301	161.2	1	SNP	p	V316P	0	.	.	946	948	GTG	1181	1183	GTG	209;208;207	G;T;G	188;183;185	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3728	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2301	161.2	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1685	1687	ACC	160;159;160	A;C;C	150;150;152	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3728	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2301	161.2	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1739	1741	GCG	167;167;167	G;C;G	144;135;139	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3728	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2301	161.2	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1739	1741	GCG	167;167;167	G;C;G	144;135;139	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3728	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2301	161.2	1	SNP	p	G543S	1	.	.	1627	1629	AGC	1862	1864	AGC	149;151;149	A;G;C	139;138;135	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3728	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2301	161.2	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1871	1873	GGC	140;137;136	G;G;C	128;128;124	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3728	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2301	161.2	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1889	1891	CCG	117;115;112	C,G;C;G	89,4;90;82	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5276	ponA	2397	2397	100.0	ponA.l6.c17.ctg.1	2974	176.7	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1563	1565	CCG	185;186;187	C;C;G	168;169;165	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1936	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1858	103.8	0	.	p	.	0	M83fs	FSHIFT	247	247	A	618	618	C	128	C	115	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2756	porB1b	1047	1047	98.95	porB1b.l15.c17.ctg.1	1434	190.7	0	.	p	.	0	K143Q	NONSYN	427	429	AAA	679	681	CAA	239;239;238	C;A;A	224;227;225	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2756	porB1b	1047	1047	98.95	porB1b.l15.c17.ctg.1	1434	190.7	0	.	p	.	0	E212S	NONSYN	634	636	GAA	886	888	AGT	203;203;204	A;G;T	196;196;192	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2756	porB1b	1047	1047	98.95	porB1b.l15.c17.ctg.1	1434	190.7	0	.	p	.	0	H213D	NONSYN	637	639	CAT	889	891	GAT	201;197;199	G;A;T	193;191;195	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2756	porB1b	1047	1047	98.95	porB1b.l15.c17.ctg.1	1434	190.7	0	.	p	.	0	V215A	NONSYN	643	645	GTT	895	897	GCT	201;197;198	G;C;T	195;192;191	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2756	porB1b	1047	1047	98.95	porB1b.l15.c17.ctg.1	1434	190.7	0	.	p	.	0	I218M	NONSYN	652	654	ATC	904	906	ATG	195;193;195	A;T;G,A	189;190;186,1	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2756	porB1b	1047	1047	98.95	porB1b.l15.c17.ctg.1	1434	190.7	0	.	p	.	0	R257K	NONSYN	769	771	AGG	1021	1023	AAG	235;238;241	A;A;G	223;225;227	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2756	porB1b	1047	1047	98.95	porB1b.l15.c17.ctg.1	1434	190.7	1	SNP	p	G120K	0	.	.	358	360	GGC	610	612	GGC	220;215;215	G;G;C,T	199;196;197,1	porB1b.WHO_P_02204c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10532	rpoB	4179	4179	99.98	rpoB.l15.c30.ctg.1	4938	213.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1162	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	981	117.1	1	SNP	p	V57M	1	.	.	169	171	ATG	586	588	ATG	239;239;242	A;T;G	229;226;229	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
